Requirements for the association of adenovirus type 2 E3/19K wild-type and mutant proteins with HLA antigens.
about
Crystal structure of adenovirus E3-19K bound to HLA-A2 reveals mechanism for immunomodulationThe endoplasmic reticulum lumenal domain of the adenovirus type 2 E3-19K protein binds to peptide-filled and peptide-deficient HLA-A*1101 molecules.Determinants of the endoplasmic reticulum (ER) lumenal-domain of the adenovirus serotype 2 E3-19K protein for association with and ER-retention of major histocompatibility complex class I moleculesAdenovirus E3-19K proteins of different serotypes and subgroups have similar, yet distinct, immunomodulatory functions toward major histocompatibility class I moleculesEarly region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroups B and CAdenovirus infection inhibits the phosphorylation of major histocompatibility complex class I proteins.Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphConserved cysteine residues within the E3/19K protein of adenovirus type 2 are essential for binding to major histocompatibility complex antigens.Role of the adenovirus E3-19k conserved region in binding major histocompatibility complex class I molecules.Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules.The transmembrane domain of the adenovirus E3/19K protein acts as an endoplasmic reticulum retention signal and contributes to intracellular sequestration of major histocompatibility complex class I molecules.Structure of the Adenovirus Type 4 (Species E) E3-19K/HLA-A2 Complex Reveals Species-Specific Features in MHC Class I Recognition.The endoplasmic reticulum retention signal of the E3/19K protein of adenovirus type 2 consists of three separate amino acid segments at the carboxy terminus.
P2860
Q27674302-59D5DF40-DA0C-4821-8315-8F0BC81AE9EAQ34092778-237B9DFC-CFCC-4D8D-A469-19C7346FCCFEQ34548615-2B44FA9B-F46C-4F3D-B46C-F8411AF4C0CEQ34978929-283468AE-D8AA-4A7F-AAA7-30CA0118BAD1Q35859922-26BC7BD2-84ED-463E-B396-4D2CD5848672Q36230566-FAA89D08-2DB6-4F07-AAEC-7391D4CB39DAQ36651837-4990F8FF-F431-4027-9E8D-34DB4B19F861Q38304802-ED971107-17A5-47FE-9567-92BD23F9C4CDQ38327143-1CB55CAE-8B90-4A3E-9C5D-38753EC889E5Q39597900-F3410331-362C-4DA7-94EA-C884B76CD44FQ40526205-B24CA378-1EA9-4779-906A-76713AEAB712Q40622863-909E696C-1CD0-4D93-8BB4-0D22A3B55319Q41716713-BE45B567-0404-48B5-83AC-EF4D85111D25
P2860
Requirements for the association of adenovirus type 2 E3/19K wild-type and mutant proteins with HLA antigens.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Requirements for the associati ...... nt proteins with HLA antigens.
@ast
Requirements for the associati ...... nt proteins with HLA antigens.
@en
type
label
Requirements for the associati ...... nt proteins with HLA antigens.
@ast
Requirements for the associati ...... nt proteins with HLA antigens.
@en
prefLabel
Requirements for the associati ...... nt proteins with HLA antigens.
@ast
Requirements for the associati ...... nt proteins with HLA antigens.
@en
P2093
P2860
P1433
P1476
Requirements for the associati ...... nt proteins with HLA antigens.
@en
P2093
P2860
P304
P407
P577
1990-08-01T00:00:00Z